The group was initiated as part of a large EU-funded program, “Application of Nanotechnology in Advanced Materials,” implemented by the EIT+ Research Center. Within this framework, we carried out an interdisciplinary project focused on the implementation of luminescent up-converting nanoparticles for biological applications, particularly in biodetection and bioimaging.

Subsequently, we conducted research in several other projects with biotechnology industry partners, including DegScreen, ANEURYSENS, FLUSENSOR, inProbe, and others. Among our applied research projects is Pellino, which focuses on specific mechanisms of immune response.

Currently, ongoing projects cover classical biotechnology, including the production of succinic acid by genetically modified bacteria (“GreenAmber”) and the development of systems for rapid, high-throughput diagnostics of SARS-CoV-2 infections (“Fibiomed”).